Matches in SemOpenAlex for { <https://semopenalex.org/work/W837848712> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W837848712 abstract "BACKGROUND: Patients with atrial fibrillation (AF) who receive both antiplatelet (AP) and anticoagulant therapy are at markedly higher risk of bleeding. The ENGAGE AF-TIMI 48 trial showed that both the high- (HD) and low-dose (LD) regimens of the once-daily factor Xa inhibitor edoxaban (Edox) were as effective as well-managed warfarin (Warf) (median TTR 68.4%) in preventing stroke or systemic embolism (SEE) with significant reductions in major bleeding and cardiovascular mortality. In this study, we assessed the relative efficacy and safety of Edox as compared with Warf in patients with and without concomitant use of AP therapy. METHODS: This was a randomized, double-blind, double-dummy trial comparing HD (60 mg daily, reduced to 30mg in patients with anticipated increased drug exposure) and LD (30 mg daily, reduced to 15mg) Edox with Warf. Dual AP therapy was prohibited while receiving study drug. Cox proportional hazards models were performed stratified by AP use at 3 months with treatment as a covariate. RESULTS: Of the 21,105 patients, 4,912 (23%) were receiving AP therapy at 3 months (92% aspirin). Patients who received concomitant AP therapy had higher rates of major bleeding compared to patients who did not (Fig). Both Edox regimens had similar relative efficacy in preventing stroke or SEE compared with Warf regardless of concomitant AP use (P int >0.10 for both) with consistent reductions in major bleeding (HD Edox vs. Warf: P int =0.91; LD Edox vs. Warf: P int =0.59). In patients randomized to LD Edox, AP therapy was associated with a further reduction in the net clinical outcome of death, stroke, SEE, or major bleeding (P int =0.02) compared with Warf. CONCLUSIONS: Regardless of concomitant AP therapy, both doses of Edox significantly reduced bleeding compared to well-managed Warf. The safety profile of Edox may be particularly attractive in patients with AF who receive a combination of AP and anticoagulant therapy because of higher absolute risk of bleeding." @default.
- W837848712 created "2016-06-24" @default.
- W837848712 creator A5003984873 @default.
- W837848712 creator A5008478781 @default.
- W837848712 creator A5016322021 @default.
- W837848712 creator A5016834175 @default.
- W837848712 creator A5019612250 @default.
- W837848712 creator A5022267024 @default.
- W837848712 creator A5078033695 @default.
- W837848712 creator A5085897222 @default.
- W837848712 creator A5087033748 @default.
- W837848712 date "2014-11-25" @default.
- W837848712 modified "2023-10-09" @default.
- W837848712 title "Abstract 19119: Concomitant Use of Antiplatelet Therapy with Edoxaban or Warfarin in Patients with Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial" @default.
- W837848712 doi "https://doi.org/10.1161/circ.130.suppl_2.19119" @default.
- W837848712 hasPublicationYear "2014" @default.
- W837848712 type Work @default.
- W837848712 sameAs 837848712 @default.
- W837848712 citedByCount "2" @default.
- W837848712 countsByYear W8378487122015 @default.
- W837848712 countsByYear W8378487122016 @default.
- W837848712 crossrefType "journal-article" @default.
- W837848712 hasAuthorship W837848712A5003984873 @default.
- W837848712 hasAuthorship W837848712A5008478781 @default.
- W837848712 hasAuthorship W837848712A5016322021 @default.
- W837848712 hasAuthorship W837848712A5016834175 @default.
- W837848712 hasAuthorship W837848712A5019612250 @default.
- W837848712 hasAuthorship W837848712A5022267024 @default.
- W837848712 hasAuthorship W837848712A5078033695 @default.
- W837848712 hasAuthorship W837848712A5085897222 @default.
- W837848712 hasAuthorship W837848712A5087033748 @default.
- W837848712 hasConcept C126322002 @default.
- W837848712 hasConcept C127413603 @default.
- W837848712 hasConcept C164705383 @default.
- W837848712 hasConcept C168563851 @default.
- W837848712 hasConcept C2776301958 @default.
- W837848712 hasConcept C2777628954 @default.
- W837848712 hasConcept C2777995511 @default.
- W837848712 hasConcept C2778661090 @default.
- W837848712 hasConcept C2779161974 @default.
- W837848712 hasConcept C2779384505 @default.
- W837848712 hasConcept C2780290652 @default.
- W837848712 hasConcept C2780400711 @default.
- W837848712 hasConcept C2780645631 @default.
- W837848712 hasConcept C500558357 @default.
- W837848712 hasConcept C71924100 @default.
- W837848712 hasConcept C78519656 @default.
- W837848712 hasConceptScore W837848712C126322002 @default.
- W837848712 hasConceptScore W837848712C127413603 @default.
- W837848712 hasConceptScore W837848712C164705383 @default.
- W837848712 hasConceptScore W837848712C168563851 @default.
- W837848712 hasConceptScore W837848712C2776301958 @default.
- W837848712 hasConceptScore W837848712C2777628954 @default.
- W837848712 hasConceptScore W837848712C2777995511 @default.
- W837848712 hasConceptScore W837848712C2778661090 @default.
- W837848712 hasConceptScore W837848712C2779161974 @default.
- W837848712 hasConceptScore W837848712C2779384505 @default.
- W837848712 hasConceptScore W837848712C2780290652 @default.
- W837848712 hasConceptScore W837848712C2780400711 @default.
- W837848712 hasConceptScore W837848712C2780645631 @default.
- W837848712 hasConceptScore W837848712C500558357 @default.
- W837848712 hasConceptScore W837848712C71924100 @default.
- W837848712 hasConceptScore W837848712C78519656 @default.
- W837848712 hasIssue "suppl_2" @default.
- W837848712 hasLocation W8378487121 @default.
- W837848712 hasOpenAccess W837848712 @default.
- W837848712 hasPrimaryLocation W8378487121 @default.
- W837848712 hasRelatedWork W154936087 @default.
- W837848712 hasRelatedWork W2027735039 @default.
- W837848712 hasRelatedWork W2038529554 @default.
- W837848712 hasRelatedWork W2063195683 @default.
- W837848712 hasRelatedWork W2096246254 @default.
- W837848712 hasRelatedWork W2121394112 @default.
- W837848712 hasRelatedWork W2152623033 @default.
- W837848712 hasRelatedWork W2160226369 @default.
- W837848712 hasRelatedWork W2165626532 @default.
- W837848712 hasRelatedWork W2206334670 @default.
- W837848712 hasRelatedWork W2499224120 @default.
- W837848712 hasRelatedWork W2776629303 @default.
- W837848712 hasRelatedWork W2811043512 @default.
- W837848712 hasRelatedWork W2900887408 @default.
- W837848712 hasRelatedWork W2960863555 @default.
- W837848712 hasRelatedWork W2991965368 @default.
- W837848712 hasRelatedWork W3030533492 @default.
- W837848712 hasRelatedWork W3045526369 @default.
- W837848712 hasRelatedWork W3084017913 @default.
- W837848712 hasRelatedWork W3164564218 @default.
- W837848712 hasVolume "130" @default.
- W837848712 isParatext "false" @default.
- W837848712 isRetracted "false" @default.
- W837848712 magId "837848712" @default.
- W837848712 workType "article" @default.